Illumina's Wild Ride: AI Hype vs. Market Reality
Markets & Money Today | 2 Min News | The Daily News Now! - Podcast autorstwa The Daily News Now! - Czwartki
Kategorie:
Illumina's Wild Ride: AI Breakthroughs Meet Investor Skepticism! Despite a new AI-powered drug discovery platform and pharma partnerships, Illumina's stock dipped after Barclays reiterated an Underweight rating. Is BioInsight enough to reverse a 25% year-to-date drop and win back wary investors? Hosted on Acast. See acast.com/privacy for more information.
